Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses

Eur J Pharmacol. 1994 Dec 27;271(2-3):319-27. doi: 10.1016/0014-2999(94)90789-7.

Abstract

Dexamethasone (sodium phosphate), pentoxifylline, fusidic acid (sodium salt), pentamidine (isethionate) and R-phenylisopropyladenosine (R-PIA) were tested for their anti-tumor necrosis factor (TNF) activities in an endotoxin-induced shock rat model. All the drugs reduced serum TNF concentrations in a dose-dependent manner, whereas their effects on serum interleukin-6 levels differed. Doses that reduced TNF levels by 50% were 0.012 mg/kg for dexamethasone, 0.06 mg/kg for R-PIA, 0.24 mg/kg for pentamidine, 6.5 mg/kg for fusidic acid and 15 mg/kg for pentoxifylline. Administration of the drugs to rats before intraplantar injection of carrageenan reduced paw edema by 50-70%. Injection of a monoclonal anti-TNF antibody reproduced the inhibitory effect. Moreover, the time course of tissue-associated TNF following carrageenan injection was compatible with mediation of edema by TNF. Results obtained for this acute, non-immunological inflammatory reaction strongly suggest that the model is TNF-dependent. Our results reinforce the idea that TNF is a crucial target in the therapeutics of inflammatory reactions. These drugs, which are able to cross cell barriers, might have clinical applications in localized and/or chronic diseases in which TNF is involved.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute-Phase Reaction / drug therapy*
  • Animals
  • Dose-Response Relationship, Drug
  • Edema / drug therapy
  • Fusidic Acid / pharmacology
  • Fusidic Acid / therapeutic use
  • Interleukin-6 / blood
  • Lipopolysaccharides / toxicity
  • Male
  • Pentamidine / pharmacology
  • Pentamidine / therapeutic use
  • Pentoxifylline / pharmacology
  • Pentoxifylline / therapeutic use
  • Phenylisopropyladenosine / pharmacology
  • Rats
  • Rats, Inbred F344
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Tumor Necrosis Factor-alpha / physiology

Substances

  • Interleukin-6
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Phenylisopropyladenosine
  • Fusidic Acid
  • Pentamidine
  • Pentoxifylline